RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with How did BPC 157 become the wellness industry's star peptide? Peptides Might Be Making a Comeback In 2023, the FDA restricted 19 peptides from compounding pharmacies. Now, regulators are reviewing a possible reversal, which could allow 14 of those peptides to RFK Jr. & claimed regenerative peptides like BPC 157 The Niche